Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings … Read more
Cizzle Biotechnology Holdings PLC (CIZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 1.199x
Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) has a cash flow conversion efficiency ratio of 1.199x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-331.00K) by net assets (GBX-276.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cizzle Biotechnology Holdings PLC - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Cizzle Biotechnology Holdings PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cizzle Biotechnology Holdings PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cizzle Biotechnology Holdings PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BURCON NUTRASCIENCE
MU:BNE
|
-0.211x |
|
Curative Biosciences Inc
PINK:CBDX
|
0.045x |
|
Yuexiu Real Estate Investment Trust
F:D3N
|
0.214x |
|
American Films Inc
PINK:AMFL
|
-0.007x |
|
Anchor Land Holdings Inc
PSE:ALHI
|
0.064x |
|
Sakana SA
WAR:SKN
|
0.160x |
|
Quice Food Industries Ltd
KAR:QUICE
|
N/A |
|
Mobilityone Ltd
LSE:MBO
|
0.906x |
Annual Cash Flow Conversion Efficiency for Cizzle Biotechnology Holdings PLC (2006–2024)
The table below shows the annual cash flow conversion efficiency of Cizzle Biotechnology Holdings PLC from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX82.00K | GBX-358.00K | -4.366x | -929.63% |
| 2023-12-31 | GBX1.51 Million | GBX-639.00K | -0.424x | -28.37% |
| 2022-12-31 | GBX2.64 Million | GBX-872.00K | -0.330x | +69.33% |
| 2021-12-31 | GBX937.00K | GBX-1.01 Million | -1.077x | +88.28% |
| 2020-12-31 | GBX32.00K | GBX-294.00K | -9.188x | -761.46% |
| 2019-12-31 | GBX6.63K | GBX-7.07K | -1.067x | -148.86% |
| 2018-12-31 | GBX-235.00K | GBX-513.00K | 2.183x | +951.36% |
| 2017-12-31 | GBX741.00K | GBX-190.00K | -0.256x | -401.49% |
| 2016-12-31 | GBX2.19 Million | GBX186.00K | 0.085x | +135.88% |
| 2015-12-31 | GBX2.40 Million | GBX-570.00K | -0.237x | -127.41% |
| 2014-12-31 | GBX5.05 Million | GBX-526.00K | -0.104x | +34.38% |
| 2013-12-31 | GBX4.27 Million | GBX-678.00K | -0.159x | -424.98% |
| 2012-12-31 | GBX4.79 Million | GBX-145.00K | -0.030x | +91.82% |
| 2011-12-31 | GBX4.08 Million | GBX-1.51 Million | -0.370x | -329.38% |
| 2010-12-31 | GBX3.54 Million | GBX-305.00K | -0.086x | +70.09% |
| 2009-12-31 | GBX521.00K | GBX-150.00K | -0.288x | +69.03% |
| 2008-12-31 | GBX1.67 Million | GBX-1.55 Million | -0.930x | -6.47% |
| 2007-12-31 | GBX2.40 Million | GBX-2.10 Million | -0.873x | -104.62% |
| 2006-12-31 | GBX-58.00K | GBX-1.10 Million | 18.914x | -- |